Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Shares Outstanding (Weighted Average): 2009-2025

Historic Shares Outstanding (Weighted Average) for Prestige Consumer Healthcare (PBH) over the last 17 years, with Sep 2025 value amounting to $49.2 million.

  • Prestige Consumer Healthcare's Shares Outstanding (Weighted Average) fell 0.69% to $49.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.2 million, marking a year-over-year decrease of 0.69%. This contributed to the annual value of $49.5 million for FY2025, which is 0.22% down from last year.
  • According to the latest figures from Q3 2025, Prestige Consumer Healthcare's Shares Outstanding (Weighted Average) is $49.2 million, which was down 0.41% from $49.4 million recorded in Q2 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Shares Outstanding (Weighted Average) registered a high of $50.3 million during Q2 2022, and its lowest value of $49.2 million during Q3 2025.
  • Over the past 3 years, Prestige Consumer Healthcare's median Shares Outstanding (Weighted Average) value was $49.6 million (recorded in 2024), while the average stood at $49.6 million.
  • In the last 5 years, Prestige Consumer Healthcare's Shares Outstanding (Weighted Average) climbed by 0.74% in 2022 and then declined by 1.17% in 2023.
  • Quarterly analysis of 5 years shows Prestige Consumer Healthcare's Shares Outstanding (Weighted Average) stood at $50.1 million in 2021, then fell by 1.15% to $49.5 million in 2022, then grew by 0.19% to $49.6 million in 2023, then decreased by 0.43% to $49.4 million in 2024, then fell by 0.69% to $49.2 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $49.2 million for Q3 2025, versus $49.4 million for Q2 2025 and $49.5 million for Q1 2025.